Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?

Alexandre Chicheportiche, Moshe Sason, Yodphat Krausz, Jeremy Godefroy, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David Gross and Simona Ben-Haim
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 18;
Alexandre Chicheportiche
1Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
2Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moshe Sason
1Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
2Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yodphat Krausz
3Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
1Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
2Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Godefroy
1Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
2Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simona Grozinsky-Glasberg
3Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
4ENETS Center of Excellence, Endocrinology and Metabolism Department Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kira Oleinikov
4ENETS Center of Excellence, Endocrinology and Metabolism Department Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amichay Meirovitz
5Oncology Department and Radiation Therapy Unit Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Gross
3Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
4ENETS Center of Excellence, Endocrinology and Metabolism Department Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simona Ben-Haim
6Institute of Nuclear Medicine University College London and UCL Hospitals NHS Trust London United Kingdom
1Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
2Department of Nuclear Medicine & Biophysics Hadassah-Hebrew University Medical Center - Ein Kerem Jerusalem Israel
3Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
Alexandre Chicheportiche, Moshe Sason, Yodphat Krausz, Jeremy Godefroy, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David Gross, Simona Ben-Haim
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 18;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
Alexandre Chicheportiche, Moshe Sason, Yodphat Krausz, Jeremy Godefroy, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David Gross, Simona Ben-Haim
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 18;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Optimal [18]F-Misonidazole PET threshold to locate SCC7 tumor hypoxia using EPR pO2 as ground truth
  • The value of 18F-FDG PET in the diagnostic workup of pediatric fever of unknown origin: a systematic review and meta-analysis
  • Prediction of absorbed dose by tumors and critical organs after Lu-177-DOTATATE therapy using pretherapeutic Ga-68-DOTATOC PET/CT
Show more Oral - PhysicianPharm

Center for Therapy Excellence Young Investigator Award Session

  • Safety and efficacy of radioligand therapy with 177lutetium-PSMA-617 within 3 months after 223Radium-dichloride
  • Progression and toxicity following liver Y90 radioembolization: impact of dose metrics, clinical factors, and biomarkers
  • Role of 68Ga-fibroblast activation protein inhibitor (FAPI) PET/CT in the evaluation of peritoneal carcinomatosis and comparison with 18F-FDG PET/CT
Show more Center for Therapy Excellence Young Investigator Award Session

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire